HK1173723A1 - Methods of treatlng poxviral infections - Google Patents
Methods of treatlng poxviral infectionsInfo
- Publication number
- HK1173723A1 HK1173723A1 HK13100313.5A HK13100313A HK1173723A1 HK 1173723 A1 HK1173723 A1 HK 1173723A1 HK 13100313 A HK13100313 A HK 13100313A HK 1173723 A1 HK1173723 A1 HK 1173723A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatlng
- methods
- poxviral
- infections
- poxviral infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
- C07D307/48—Furfural
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27225209P | 2009-09-04 | 2009-09-04 | |
PCT/US2010/047498 WO2011028781A1 (en) | 2009-09-04 | 2010-09-01 | Methods of treating poxviral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1173723A1 true HK1173723A1 (en) | 2013-05-24 |
Family
ID=43649619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13100313.5A HK1173723A1 (en) | 2009-09-04 | 2013-01-09 | Methods of treatlng poxviral infections |
Country Status (9)
Country | Link |
---|---|
US (2) | US20110065753A1 (ja) |
EP (1) | EP2473493B1 (ja) |
JP (1) | JP5575246B2 (ja) |
KR (1) | KR101459530B1 (ja) |
CN (1) | CN102625801B (ja) |
CA (1) | CA2772807A1 (ja) |
ES (1) | ES2485623T3 (ja) |
HK (1) | HK1173723A1 (ja) |
WO (1) | WO2011028781A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2398321B1 (en) | 2009-02-23 | 2015-11-25 | United Therapeutics Corporation | Iminosugars and methods of treating viral diseases |
KR20150035767A (ko) | 2012-06-06 | 2015-04-07 | 유니터 바이롤로지, 엘엘씨 | 신규 이미노당 및 그의 용도 |
WO2014143999A1 (en) * | 2013-03-15 | 2014-09-18 | Unither Virology, Llc | Antibacterial compounds |
BR112016005417A8 (pt) | 2013-09-16 | 2020-02-18 | Emergent Virology Llc | "compostos derivados de desoxinojirimicina, composição farmacêutica e seus usos" |
EP3215499B1 (en) | 2014-11-05 | 2021-01-20 | Emergent Virology LLC | Iminosugars useful for the treatment of viral diseases |
WO2017201030A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating viral infection |
US10176965B1 (en) | 2017-07-05 | 2019-01-08 | ICT Integrated Circuit Testing Gesellschaft für Halbleiterprüftechnik mbH | Aberration-corrected multibeam source, charged particle beam device and method of imaging or illuminating a specimen with an array of primary charged particle beamlets |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1555654A (en) * | 1977-06-25 | 1979-11-14 | Exxon Research Engineering Co | Agricultural burner apparatus |
NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
DE2834122A1 (de) * | 1978-08-03 | 1980-02-14 | Bayer Ag | Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose |
DE2839309A1 (de) * | 1978-09-09 | 1980-03-27 | Bayer Ag | 3,4,5-trihydroxypiperidin-derivate |
DE2853573A1 (de) * | 1978-12-12 | 1980-07-03 | Bayer Ag | Herstellung von n-substituierten derivaten des l-desoxynojirimycins |
DE3038901A1 (de) * | 1980-10-15 | 1982-05-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins |
DE3611841A1 (de) * | 1986-04-09 | 1987-10-15 | Bayer Ag | Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten |
DE3814549A1 (de) * | 1987-10-30 | 1989-05-18 | Bayer Ag | N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln |
US5144037A (en) * | 1988-11-03 | 1992-09-01 | G. D. Searle & Co. | 1,5-dideoxy-1,5-imino-d-glucitol derivatives |
US5043273A (en) * | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
US5103008A (en) * | 1989-08-17 | 1992-04-07 | Monsanto Company | Compound, N-butyl-deoxynojirimycin-6-phosphate |
US4994572A (en) * | 1989-10-12 | 1991-02-19 | Monsanto Company | Synthesis of nojirimycin derivatives |
US5030638A (en) * | 1990-02-26 | 1991-07-09 | G. D. Searle & Co. | Method of antiviral enhancement |
US5200523A (en) * | 1990-10-10 | 1993-04-06 | Monsanto Company | Synthesis of nojirimycin derivatives |
US5206251A (en) * | 1992-04-01 | 1993-04-27 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
US5399567A (en) * | 1993-05-13 | 1995-03-21 | Monsanto Company | Method of treating cholera |
WO1995022975A1 (en) * | 1994-02-25 | 1995-08-31 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
EP1037636A4 (en) * | 1997-12-11 | 2004-08-18 | Univ Oxford | INHIBITATION OF MEMBRANE-TIED VIRAL REPLICATION |
US6689759B1 (en) * | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
ATE331515T1 (de) * | 1998-02-12 | 2006-07-15 | Searle Llc | Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen |
US6610703B1 (en) * | 1998-12-10 | 2003-08-26 | G.D. Searle & Co. | Method for treatment of glycolipid storage diseases |
GB9828474D0 (en) * | 1998-12-24 | 1999-02-17 | British Aerospace | Surface topology inspection |
AU3595500A (en) * | 1999-02-12 | 2000-08-29 | G.D. Searle & Co. | Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
GB0100889D0 (en) * | 2001-01-12 | 2001-02-21 | Oxford Glycosciences Uk Ltd | Compounds |
WO2001007078A1 (en) * | 1999-07-26 | 2001-02-01 | G.D. Searle & Co. | Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of medicament for the treatment of glycolipid storage diseases |
US7256005B2 (en) * | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
ES2531478T3 (es) * | 2003-01-31 | 2015-03-16 | The Mount Sinai School Of Medicine Of New York University | Terapia de combinación para tratar trastornos de deficiencia de proteínas |
US7446098B2 (en) * | 2003-02-18 | 2008-11-04 | Mount Sinai School Of Medicine Of New York University | Combination therapy for treating protein deficiencies |
US20060211752A1 (en) * | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
US20050256168A1 (en) * | 2004-04-28 | 2005-11-17 | Block Timothy M | Compositions for oral administration for the treatment of interferon-responsive disorders |
US7524829B2 (en) * | 2004-11-01 | 2009-04-28 | Avi Biopharma, Inc. | Antisense antiviral compounds and methods for treating a filovirus infection |
GB0501352D0 (en) * | 2005-01-21 | 2005-03-02 | Slingsby Jason H | Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope |
EP2058004A1 (en) * | 2005-03-16 | 2009-05-13 | University of Oxford | Mannose immunogens for HIV-1 |
US9181184B2 (en) * | 2005-05-17 | 2015-11-10 | Amicus Therapeutics, Inc. | Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
JP2009507770A (ja) * | 2005-07-27 | 2009-02-26 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド | 眼性疾患の治療への、熱ショックの使用 |
AU2006272497B2 (en) * | 2005-07-27 | 2012-07-19 | University Of Florida Research Foundation, Inc. | Small compounds that correct protein misfolding and uses thereof |
US20070244184A1 (en) * | 2006-01-09 | 2007-10-18 | Simon Fraser University | Glycosidase inhibitors and methods of synthesizing same |
ATE479696T1 (de) * | 2006-04-24 | 2010-09-15 | Amc Amsterdam | Verbessertes verfahren zur behandlung von cystischer fibrose |
CA2652958C (en) * | 2006-05-24 | 2015-11-17 | United Therapeutics Corporation | Deoxynojirimycin and d-arabinitol analogs and methods of using |
EP2399587A1 (en) * | 2006-08-02 | 2011-12-28 | The University of Oxford | Liposome treatment of viral infections |
CA2666814A1 (en) * | 2006-08-21 | 2008-05-29 | United Therapeutics Corporation | Combination therapy for treatment of viral infections |
EP2282723A2 (en) * | 2008-03-26 | 2011-02-16 | University of Oxford | Endoplasmic reticulum targeting liposomes |
-
2010
- 2010-09-01 CA CA2772807A patent/CA2772807A1/en not_active Abandoned
- 2010-09-01 US US12/873,705 patent/US20110065753A1/en not_active Abandoned
- 2010-09-01 CN CN201080048401.4A patent/CN102625801B/zh not_active Expired - Fee Related
- 2010-09-01 WO PCT/US2010/047498 patent/WO2011028781A1/en active Application Filing
- 2010-09-01 EP EP10814414.8A patent/EP2473493B1/en not_active Not-in-force
- 2010-09-01 ES ES10814414.8T patent/ES2485623T3/es active Active
- 2010-09-01 JP JP2012528005A patent/JP5575246B2/ja not_active Expired - Fee Related
- 2010-09-01 KR KR1020127007710A patent/KR101459530B1/ko not_active IP Right Cessation
-
2013
- 2013-01-09 HK HK13100313.5A patent/HK1173723A1/xx not_active IP Right Cessation
-
2016
- 2016-05-04 US US15/145,992 patent/US20160243097A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102625801A (zh) | 2012-08-01 |
KR20120048697A (ko) | 2012-05-15 |
EP2473493A1 (en) | 2012-07-11 |
CN102625801B (zh) | 2015-09-09 |
US20110065753A1 (en) | 2011-03-17 |
US20160243097A1 (en) | 2016-08-25 |
CA2772807A1 (en) | 2011-03-10 |
JP2013503882A (ja) | 2013-02-04 |
JP5575246B2 (ja) | 2014-08-20 |
ES2485623T3 (es) | 2014-08-13 |
EP2473493A4 (en) | 2013-01-09 |
WO2011028781A1 (en) | 2011-03-10 |
KR101459530B1 (ko) | 2014-11-07 |
EP2473493B1 (en) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP3269A (en) | Methods and compounds for treating paramyxoviridaevirus infections | |
EP2480255A4 (en) | THERAPY FOR ENTERIC INFECTIONS | |
HK1217763A1 (zh) | 用於治療疾病的方法 | |
HK1173723A1 (en) | Methods of treatlng poxviral infections | |
PL2696890T3 (pl) | Leczenie infekcji drobnoustrojowych | |
HRP20160150T1 (en) | Treatment of streptococcal infections | |
EP2408473A4 (en) | METHODS OF VACCINATION | |
IL256026B (en) | Treatment methods | |
DK2473482T3 (en) | Methods of treating orthomyxoviral infections | |
EP2424559A4 (en) | METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS WITH ORITAVANCIN | |
EP2522360A4 (en) | VACCINE FOR TAUTOPATHY TREATMENT | |
EP2536282A4 (en) | METHOD FOR THE TREATMENT OF INFECTIONS | |
EP2440415A4 (en) | MATRIX ALIGNMENT | |
EP2403507A4 (en) | TREATMENT OF INFECTIONS | |
ZA201204249B (en) | Treatment of microbial infections | |
EP2585103A4 (en) | METHOD OF TREATMENT | |
PL2431030T3 (pl) | Leczenie infekcji grzybiczych | |
EP2440238A4 (en) | Methods of Treatment | |
AU2009905173A0 (en) | Methods of treatment | |
AU2009904460A0 (en) | Methods of treatment | |
AU2009902633A0 (en) | Methods of treatment | |
GB0921823D0 (en) | Method of treatment | |
GB0909807D0 (en) | Method of treatment | |
GB0904164D0 (en) | Method of treatment | |
GB0918850D0 (en) | Shellfish treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180824 |